1. Home
  2. HIMX vs ARQT Comparison

HIMX vs ARQT Comparison

Compare HIMX & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Himax Technologies Inc.

HIMX

Himax Technologies Inc.

HOLD

Current Price

$8.47

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$26.23

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIMX
ARQT
Founded
2001
2016
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
3.3B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
HIMX
ARQT
Price
$8.47
$26.23
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$24.83
AVG Volume (30 Days)
827.1K
1.8M
Earning Date
02-12-2026
02-24-2026
Dividend Yield
4.35%
N/A
EPS Growth
N/A
N/A
EPS
0.36
N/A
Revenue
$866,315,000.00
$317,929,000.00
Revenue This Year
N/A
$85.83
Revenue Next Year
$9.99
$30.72
P/E Ratio
$23.87
N/A
Revenue Growth
N/A
129.21
52 Week Low
$5.66
$11.13
52 Week High
$13.91
$31.77

Technical Indicators

Market Signals
Indicator
HIMX
ARQT
Relative Strength Index (RSI) 53.07 39.57
Support Level $8.05 $25.35
Resistance Level $8.64 $26.93
Average True Range (ATR) 0.27 1.45
MACD 0.01 -0.43
Stochastic Oscillator 54.67 17.04

Price Performance

Historical Comparison
HIMX
ARQT

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: